FINWIRES · TerminalLIVE
FINWIRES

Pilbara Gold Satisfies All Conditions Precedent Under PLS Group Mineral Rights Agreement, Shares Up 6%

By

Pilbara Gold (ASX:PGL) said all conditions precedent in its Mineral Rights Agreement with PLS Group (ASX:PLS), entered into in October 2025, have now been satisfied at its 2.1 million-ounce Mt York gold project in Western Australia, according to a Monday Australian bourse filing.

The company said it now owns mineral rights, excluding lithium and tantalum, to three PLS exploration licences and one application covering 367 square kilometers of neighboring prospective greenstone geology at Mt York.

Pilbara Gold will start a large airborne electromagnetic survey over the greater Mt York region to define new targets over nearby prospective geology, the filing added.

The company's shares rose 6% in recent Monday trade.

Related Articles

Asia

Aspial Lifestyle's H1 Attributable Profit Surges 88%

Aspial Lifestyle's (SGX:5UF) recorded an 88% rise in attributable profit in the first half of 2026 to SG$52.4 million from SG$27.9 million a year prior.Earnings per share stood at SG$0.0277, up from SG$0.015 previously, according to a Friday filing with the Singapore bourse.Revenue jumped 26% to SG$464.2 million from SG$367.2 million in the year-ago period.

SGX:5UF
Asia

Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug

Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group's Benmelstobart Injection obtained marketing approval from China's National Medical Products Administration, according to a Friday Hong Kong bourse filing.The approval is for use of the drug in combination with chemotherapy and sequentially followed by Anlotinib Hydrochloride Capsules for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer.

HKG:1177
Asia

Lygend Resources Gets CSRC Nod for China Listed-Share IPO

Lygend Resources & Technology (HKG:2245) obtained approval for its registration application related to its China listed-share initial public offering from the China Securities Regulatory Commission (CSRC).The share offering is subject to various conditions, including certain final regulatory approvals, according to a Friday Hong Kong bourse filing.

HKG:2245